International Business Design focused on Asia, the US and UAE



Service ID:

Service description

Build capacity for agile market entry and expansion through co-creation and co-design via individual training and coaching tailored to the needs of biomedical technology, medical technology, biotech and pharma industry.

The guidance will navigate through innovative business models, commercialisation, Go2Market, and reimbursement strategies, considering its current TRL level and the value chain. 

Key features:

  • Business model optimisation with review & analysis.
  • Business strategy optimisation with review & analysis.
  • Commercialisation strategy optimisation with review & analysis.
  • Regulatory gap analysis and reimbursement strategy.
  • Market entry strategy analysis.
  • Growth hacking.
  • Distribution channels with cost estimation analysis.
  • Strategic partnerships & agreement negotiation.

Benefits for EIC beneficiaries in i) research stage, ii) spinout/startup, iii) scale-up:

  • Ensure your local market fit: Align policies with the local legislation and business practices.
  • Secure revenues and stay ahead of competitors: Incorporate a feasible reimbursement strategy according to the local legislation.
  • Accelerate market entry: Understand how the local health ecosystem works and align the go2market strategies accordingly.
  • Clinical evaluations: Prepare in advance in case they are required for market accession. Also, use them in assessing the pricing model.
  • Product success: Ensure that reimbursement strategies fit the target market regulatory requirement optimally.

The service is directed to EIC pathfinder, EIC transition and EIC accelerator innovators by dedicated in-house or external experts depending on the target market via online, offline or hybrid models.

Health and medical care
Technology Readiness Level
TRL 1 – Basic principles observed
TRL 2 – Technology concept formulated
TRL 3 – Experimental proof of concept
TRL 4 – Technology validated in lab
TRL 5 – Technology validated in relevant environment
TRL 6 – Technology demonstrated in relevant environment
TRL 7 – System prototype demonstration in operational environment
TRL 8 – System complete and qualified
TRL 9 – Actual system proven in operational environment
Disclaimer related to service

The service is directed to EIC beneficiaries from the HealthTech, MedTech, BioMedTech and Biotech & Pharma sectors. Governmental fees are charged additionally if applicable.

Financial requirements

Hourly fee varies from €150 to €600 depending on the innovation, healthcare sector and targeted market area(s).